The DOI matches its Crossref record.
Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis
Abstract
Objective: To examine how anti–citrullinated protein antibody (ACPA) epitope spreading takes place prior to the onset of clinical rheumatoid arthritis (RA), and to analyze the pattern of autoantigen reactivity at the beginning of the immune response. Methods: Multiple consecutive serum samples from 79 RA patients who had donated blood before disease onset were available for analysis. Fifty‐three patients tested positive for ACPAs prior to the onset of clinical RA. For these patients, a median of 6 (interquartile range 4–9) sequential pre‐RA serum samples obtained 1–2 years apart were tested. Reactivity to 5 distinct citrullinated peptides was measured by enzyme‐linked immunosorbent assay. Two peptides were derived from fibrinogen, 1 from vimentin, 1 from α‐enolase, and 1 from filaggrin. Results: In 25 of 53 ACPA‐positive patients, seroconversion from ACPA absence to ACPA presence was observed. In 72% of these patients, the immune response started with reactivity to 1 peptide, without preference for a particular peptide. The number of peptides recognized increased over time, without a dominant epitope‐spreading pattern. ACPAs appeared in low levels several years prior to the diagnosis of RA. Antibody titers increased markedly ∼2–4 years before diagnosis. Conclusion: Our findings indicate that ACPA epitope spreading occurs over several years prior to the onset of clinical RA. The initial autoimmune response is mostly directed toward only 1 autoantigen, but this is not always the same antigen. The marked increase in ACPA titers a few years prior to the diagnosis of RA suggests a second stage in disease development, which might be due to a variety of factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis
van der Woude, D., & van der Helm-van Mil, A. H. M. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.10.005 · Cited by 479
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Suurmond, J., & Diamond, B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78084 · Cited by 337
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
Horta-Baas, G., Romero-Figueroa, M. D. S., Montiel-Jarquín, A. J., Pizano-Zárate, M. L., García-Mena, J., & Ramírez-Durán, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/4835189 · Cited by 324
Rombouts, Y., Ewing, E., van de Stadt, L. A., Selman, M. H. J., Trouw, L. A., Deelder, A. M., Huizinga, T. W. J., Wuhrer, M., van Schaardenburg, D., Toes, R. E. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203565 · Cited by 288
Self-citation
Metadata
- Authors
- van de Stadt, L. A., de Koning, M. H. M. T., van de Stadt, R. J., Wolbink, G., Dijkmans, B. A. C., Hamann, D., & van Schaardenburg, D.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-10-28
- Volume
- 63
- Issue
- 11
- Pages
- 3226-3233
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2064349379
- Cited by
- 226
- References
- 0
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.30537
- The paper
- van de Stadt, L. A., de Koning, M. H. M. T., van de Stadt, R. J., Wolbink, G., Dijkmans, B. A. C., Hamann, D., & van Schaardenburg, D. (2011). Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.30537
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.